The pharmacokinetics and clinical efficacy of AVP-825: a potential advancement for acute treatment of migraine.
about
Sumatriptan Nasal Powder: A Review in Acute Treatment of Migraine.Triptans and migraine: advances in use, administration, formulation, and development.AVP-825 (Sumatriptan Nasal Powder) Reduces Nausea Compared to Sumatriptan Tablets: Results of the COMPASS Randomized Clinical Trial.A review of clinical safety data for sumatriptan nasal powder administered by a breath powered exhalation delivery system in the acute treatment of migraine.
P2860
The pharmacokinetics and clinical efficacy of AVP-825: a potential advancement for acute treatment of migraine.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The pharmacokinetics and clini ...... r acute treatment of migraine.
@en
type
label
The pharmacokinetics and clini ...... r acute treatment of migraine.
@en
prefLabel
The pharmacokinetics and clini ...... r acute treatment of migraine.
@en
P2860
P1476
The pharmacokinetics and clini ...... r acute treatment of migraine.
@en
P2093
Roger Cady
P2860
P304
P356
10.1517/14656566.2015.1074178
P407
P577
2015-09-01T00:00:00Z